An antibody Fc engineered for conditional antibody-dependent cellular cytotoxicity at the low tumor microenvironment pH

J Biol Chem. 2022 Apr;298(4):101798. doi: 10.1016/j.jbc.2022.101798. Epub 2022 Mar 3.

Abstract

Despite the exquisite specificity and high affinity of antibody-based cancer therapies, treatment side effects can occur since the tumor-associated antigens targeted are also present on healthy cells. However, the low pH of the tumor microenvironment provides an opportunity to develop conditionally active antibodies with enhanced tumor specificity. Here, we engineered the human IgG1 Fc domain to enhance pH-selective binding to the receptor FcγRIIIa and subsequent antibody-dependent cellular cytotoxicity (ADCC). We displayed the Fc domain on the surface of mammalian cells and generated a site-directed library by altering Fc residues at the Fc-FcγRIIIa interface to support interactions with positively charged histidine residues. We then used a competitive staining and flow cytometric selection strategy to isolate Fc variants exhibiting reduced FcγRIIIa affinities at neutral pH, but physiological affinities at the tumor-typical pH 6.5. We demonstrate that antibodies composed of Fab arms binding the breast cell epithelial marker Her2 and the lead Fc variant, termed acid-Fc, exhibited an ∼2-fold pH-selectivity for FcγRIIIa binding based on the ratio of equilibrium dissociation constants Kd,7.4/Kd,6.5, due to a faster dissociation rate at pH 7.4. Finally, in vitro ADCC assays with human FcγRIIIa-positive natural killer and Her2-positive target cells demonstrated similar activities for anti-Her2 antibodies bearing the wild-type or acid-Fc at pH 6.5, but nearly 20-fold reduced ADCC for acid-Fc at pH 7.4, based on EC50 ratios. This work shows the promise of mammalian cell display for Fc engineering and the feasibility of pH-selective Fc activation to provide a second dimension of selective tumor cell targeting.

Keywords: antibody engineering; antibody-dependent cellular cytotoxicity; conditional activity; histidine scanning; mammalian display; pH selectivity; protein engineering; tumor microenvironment.

MeSH terms

  • Antibody-Dependent Cell Cytotoxicity*
  • Humans
  • Hydrogen-Ion Concentration
  • Immunoglobulin Fc Fragments* / immunology
  • Immunoglobulin Fc Fragments* / therapeutic use
  • Immunoglobulin G / chemistry
  • Immunoglobulin G / genetics
  • Receptors, IgG / chemistry
  • Receptors, IgG / metabolism
  • Tumor Microenvironment*

Substances

  • Immunoglobulin Fc Fragments
  • Immunoglobulin G
  • Receptors, IgG